JPWO2019243893A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019243893A5
JPWO2019243893A5 JP2020570569A JP2020570569A JPWO2019243893A5 JP WO2019243893 A5 JPWO2019243893 A5 JP WO2019243893A5 JP 2020570569 A JP2020570569 A JP 2020570569A JP 2020570569 A JP2020570569 A JP 2020570569A JP WO2019243893 A5 JPWO2019243893 A5 JP WO2019243893A5
Authority
JP
Japan
Prior art keywords
lif
amino acid
acid sequence
seq
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020570569A
Other languages
English (en)
Japanese (ja)
Other versions
JP7570929B2 (ja
JP2021528411A (ja
JP2021528411A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/000756 external-priority patent/WO2019243893A1/en
Publication of JP2021528411A publication Critical patent/JP2021528411A/ja
Publication of JPWO2019243893A5 publication Critical patent/JPWO2019243893A5/ja
Publication of JP2021528411A5 publication Critical patent/JP2021528411A5/ja
Application granted granted Critical
Publication of JP7570929B2 publication Critical patent/JP7570929B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020570569A 2018-06-18 2019-06-17 Ｌｉｆを定量化する方法及びその使用 Active JP7570929B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382433.3 2018-06-18
EP18382433 2018-06-18
PCT/IB2019/000756 WO2019243893A1 (en) 2018-06-18 2019-06-17 Methods of quantifying lif and uses thereof

Publications (4)

Publication Number Publication Date
JP2021528411A JP2021528411A (ja) 2021-10-21
JPWO2019243893A5 true JPWO2019243893A5 (https=) 2022-06-24
JP2021528411A5 JP2021528411A5 (https=) 2022-06-24
JP7570929B2 JP7570929B2 (ja) 2024-10-22

Family

ID=62716028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020570569A Active JP7570929B2 (ja) 2018-06-18 2019-06-17 Ｌｉｆを定量化する方法及びその使用

Country Status (5)

Country Link
US (1) US20210190798A1 (https=)
EP (1) EP3806960A1 (https=)
JP (1) JP7570929B2 (https=)
CN (1) CN112654395A (https=)
WO (1) WO2019243893A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020354255A1 (en) 2019-09-29 2022-04-21 Jacobio Pharmaceuticals Co., Ltd. Binding molecule specific for LIF and use thereof
EP4069736A1 (en) * 2019-12-04 2022-10-12 MedImmune Limited Antibodies against lif and uses thereof
CN116298320B (zh) * 2023-03-31 2025-07-11 深圳迈瑞生物医疗电子股份有限公司 检测白血病抑制因子的试剂盒及检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057144A2 (en) * 2009-11-06 2011-05-12 La Jolla Institute For Allergy And Immunology Methods for modulating lif activity, treating immune disorders and diseases, and stimulatings immune responses
WO2015040243A2 (en) * 2013-09-23 2015-03-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for targeting tumor microenvironment and for preventing metastasis
US10583191B2 (en) * 2016-12-19 2020-03-10 Mosaic Biomedicals Slu Antibodies against LIF and uses thereof

Similar Documents

Publication Publication Date Title
JP6849751B2 (ja) 可溶性ヒトｓｔ−２抗体およびアッセイ法
Price et al. Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus
Boozer et al. Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies
US20240092925A1 (en) Cd5-targeting fully humanized antibody
Weeraratne et al. Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interference
JP2021528411A5 (https=)
AU2019251973B2 (en) Methods for quantifying IL-33
WO2013141716A1 (en) Biomarkers
CN112390890B (zh) 一种定量检测血清中抗人白介素17单克隆抗体含量的酶联免疫分析方法
US11359112B2 (en) Coatings with tunable amine density
US12037311B2 (en) Pre-assembled, protected, chemically stable, chemoselective linkers
KR102017241B1 (ko) C-반응성 단백질에 특이적으로 결합하는 항체 및 이의 용도
JPWO2019243893A5 (https=)
Chiari et al. Peptide microarrays for the characterization of antigenic regions of human chromogranin A
Park et al. Evolutionary identification of affinity peptides for the detection of sepsis biomarker procalcitonin
Sreenivasan et al. Does interaction of monoclonal antibody charge variants with VEGF-A and ELISA reagents affect its quantification?
JP2009114092A (ja) 慢性肝炎、肝硬変、肝がんの分別診断のための新規バイオマーカーおよび該バイオマーカーを用いた慢性肝炎、肝硬変、肝がんの分別診断方法
Martin et al. Surface plasmon resonance investigations of human epidermal growth factor receptor 2
JP2022506108A5 (https=)
Ko et al. Fluorescence immunoassay of anti-cyclic citrulinated peptide (CCP) autoantibodies by using parylene-H film
EP3756009B1 (en) Methods of screening antigen-binding molecules by normalizing for the concentration of antigen-binding molecule
WO2008021263A2 (en) Methods of indentifying antibodies that bind oligomeric forms of chemokines and uses thereof
CN115991776A (zh) 一种靶向cd7的全人源抗体及其应用
JPWO2022120286A5 (https=)
CN114729943B (zh) 用大分子调节剂进行il-17靶接合测定的组合物和方法